ArticleInternational journal of nanomedicine2025

Formulation and Evaluation of VCAM-1-Targeted Methotrexate Lipid Nanoparticles for Rheumatoid Arthritis Therapy.

Ren Na et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.